2 recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow Clear Scientific, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade Naloxone Hydrochloride, Fentanyl, Sterile Saline - Fentanyl Overdose, Fentanyl Poisoning | Phase 2 | Recruiting | Clear Scientific, Inc. | 16 | 2026-05-28 | 2026-08-24 |
| A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine Methamphetamine, Sterile Saline, CS-1103 - Methamphetamine Intoxication, Methamphetamine Disorders | Phase 2 | Recruiting | Clear Scientific, Inc. | 40 | 2026-02-05 | 2026-10-21 |
| A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants CS-1103, Sterile Saline - Substance Use Disorders, Methamphetamine Abuse | Phase 1 | Completed | Clear Scientific, Inc. | 32 | 2024-02-07 | 2025-11-10 |
Substance-Related Disorders (1)
Fentanyl (1) · Methamphetamine (1) · Naloxone (1)
United States (3)
Xinhua Li, Ph.D. (2)
5UG3DA059286 (1), U01DA053054 (1), U01DA058548 (1)